Home
>
National Drug Code (NDC)
>
Aralast
Aralast - 0944-2802-02 - (alpha-1 proteinase inhibitor human)
Drug Information of Aralast
| Product NDC: | 0944-2802 |
| Proprietary Name: | Aralast |
| Non Proprietary Name: | alpha-1 proteinase inhibitor human |
| Active Ingredient(s): | & nbsp; alpha-1 proteinase inhibitor human |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Aralast
| Product NDC: | 0944-2802 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125039 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20100419 |
Package Information of Aralast
| Package NDC: | 0944-2802-02 |
| Package Description: | 1 KIT in 1 CARTON (0944-2802-02) * 1 VIAL, GLASS in 1 CARTON > 50 mL in 1 VIAL, GLASS * 1 VIAL, GLASS in 1 CARTON > 50 mL in 1 VIAL, GLASS |
NDC Information of Aralast
| NDC Code | 0944-2802-02 |
| Proprietary Name | Aralast |
| Package Description | 1 KIT in 1 CARTON (0944-2802-02) * 1 VIAL, GLASS in 1 CARTON > 50 mL in 1 VIAL, GLASS * 1 VIAL, GLASS in 1 CARTON > 50 mL in 1 VIAL, GLASS |
| Product NDC | 0944-2802 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | alpha-1 proteinase inhibitor human |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 20100419 |
| Marketing Category Name | BLA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
